The Open University's first one-day symposium on treatment-emergent neuroendocrine prostate cancer.

Rebecca L. Mather, Henry Andrews, Hardev Pandha, Elena Jachetti, Jake Micallef, Yuzhuo Wang, Francesco Crea

Research output: Contribution to journalArticlepeer-review

Abstract

The Open University's first one-day symposium on treatment-emergent neuroendocrine prostate cancer attracted world-leading figures, early career researchers and industry colleagues. The symposium proved insightful into the 'real-world' impact and current problems faced in the diagnosis and treatment of neuroendocrine prostate cancer. It was important for this meeting to take place as the incidence of neuroendocrine prostate cancer is increasing due to the widespread use of next-generation androgen deprivation drugs. The symposium discussions proposed new molecularly driven deadlines to accelerate research and improved the treatment of this deadly and poorly recognized malignancy.
Original languageEnglish
JournalFuture Oncology
Issue number6
Publication statusPublished - Feb 1 2020

Fingerprint

Dive into the research topics of 'The Open University's first one-day symposium on treatment-emergent neuroendocrine prostate cancer.'. Together they form a unique fingerprint.

Cite this